Genotypic Resistance-guided Versus Empirical Therapy for H. Pylori Eradication.
Status:
Unknown status
Trial end date:
2020-02-28
Target enrollment:
Participant gender:
Summary
This study aims to investigate the efficacy of a 7-day genotypic resistance-guided triple
therapy, compared with empirical concomitant therapy, for first-line eradication of H.
pylori.
Phase:
Phase 4
Details
Lead Sponsor:
Konstantopoulio-Patission General Hospital of Nea Ionia